Tianqing Wu

3PUBLICATIONS
5CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 11, 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

Wenxuan Li, Zhikai Zheng, Jiongliang Wang

|Dec 07, 2023
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.

Tianqing Wu, Zhikai Zheng, Jiongliang Wang

|Dec 06, 2023
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy.

Zhikai Zheng, Jiongliang Wang, Tianqing Wu

Pageof 1

Frequent Collaborators

3 joint publications

Zhikai Zheng

3 joint publications

Yangxun Pan

3 joint publications

Jinbin Chen

3 joint publications

Li Xu